IL17A and chronic obstructive pulmonary disease: In chronic infections, such as those observed in patients with chronic obstructive pulmonary disease (COPD), excessive release of IL-17 has a dual effect: it contributes to bacterial clearance and can also lead to prolonged inflammation and tissue damage [46].